(Q82520283)
Statements
Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion: Japan Alteplase Clinical Trial II (J-ACT II) (English)
1 reference
14 December 2021
Etsuro Mori
Kazuo Minematsu
Jyoji Nakagawara
Takenori Yamaguchi
Makoto Sasaki
Teruyuki Hirano
Japan Alteplase Clinical Trial II Group